Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes
NCT00474838Phase 4Completed
- Sponsor
- Kyung Hee University Medical Center
- Start
- Apr 2007
- Primary completion
- Aug 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin glulisine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Kyung Hee University Medical Center. Primary endpoints: Long-term glycemic control up to 2 years and Change of pancreatic beta cell function up to 2 years. Started Apr 2007; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00474838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474838.